ALA — Arovella Therapeutics Share News
0.000.00%
Last trade - 00:00- AU$61.65m
- AU$47.30m
- AU$0.80m
Australia Stock Exchange release from AROVELLA THERAPE : Final Director's Interest Notice
Australia Stock Exchange release from AROVELLA THERAPE : Arovella to present at Biotech Showcase 2022
Australia Stock Exchange release from AROVELLA THERAPE : Change of Director's Interest Notice x 4
Australia Stock Exchange release from AROVELLA THERAPE : Notification regarding unquoted securities - ALA
Australia Stock Exchange release from AROVELLA THERAPE : Results of Annual General Meeting
Australia Stock Exchange release from AROVELLA THERAPE : PRE_NR Ends: 09:59:52
Australia Stock Exchange release from AROVELLA THERAPE : AGM FY21 Presentation
Australia Stock Exchange release from AROVELLA THERAPE : PRE_NR Ends: 09:40:25
Australia Stock Exchange release from AROVELLA THERAPE : Arovella licences novel monoclonal antibody from MD Anderson
Australia Stock Exchange release from AROVELLA THERAPE : PRE_NR Ends: 13:28:10
Australia Stock Exchange release from AROVELLA THERAPE : R&D Tax Incentive refund received
Australia Stock Exchange release from SUDA PHARMA : SUDA becomes Arovella Therapeutics
Brief: Arovella Therapeutics Ltd Says Chile Ministry Of Health Approval Granted For Zolpimist
Australia Stock Exchange release from SUDA PHARMA : Chile Ministry of Health Approval Granted for ZolpiMist
Australia Stock Exchange release from SUDA PHARMA : PRE_NR Ends: 10:11:30
Australia Stock Exchange release from SUDA PHARMA : Results of General Meeting
Australia Stock Exchange release from SUDA PHARMA : GM presentation
Australia Stock Exchange release from SUDA PHARMA : PRE_NR Ends: 09:44:31
Australia Stock Exchange release from SUDA PHARMA : Appendix 4G and Corporate Governance Statement 2021